ArticleJournal of experimental & clinical cancer research : CR2026

TWIST1 bridges p53 and MDM2 and impairs the efficacy of MDM2 inhibitors.

Sara Piccinin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.